Results 261 to 270 of about 63,662 (384)
m6A deposition: a boost from TGFβ [PDF]
Lior Lasman, Jacob H. Hanna
openaire +2 more sources
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo +11 more
wiley +1 more source
Meta-unstable mRNAs in activated CD8<sup>+</sup> T cells are defined by interlinked AU-rich elements and m<sup>6</sup>A mRNA methylation. [PDF]
Gameiro PA +13 more
europepmc +1 more source
METTL3 mediated ferroptosis in chondrocytes and promoted pain in KOA via HMGB1 m6A modification [PDF]
Tianchi Bao +8 more
openalex +1 more source
m6A modulates RNA structure [PDF]
openaire +1 more source
Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian +8 more
wiley +1 more source
m6A modification on ncRNAs and underlying mechanisms of exercise in the regulation of pathological cardiac remodeling. [PDF]
Yin G, He X, Chen N.
europepmc +1 more source
Peripheral Nerves in Cancer: Regulatory Roles and Therapeutic Strategies
The interaction between cancer cells and peripheral nerves: (1) tumor cells could induce the growth of new neural axons and constructing a neural fiber network within the tumor tissue through secreting nerve growth factors; (2) nerve‐derived bioactive molecules can induce perineural invasion of tumor and regulate the malignant phenotype of tumor, such ...
Yan Fu +6 more
wiley +1 more source
The latest progression of N6-methyladenosine (m<sup>6</sup>A) RNA modification in diabetes mellitus and diabetic complications. [PDF]
Yin G +5 more
europepmc +1 more source

